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Abstract
The vast majority of maintenance dialysis patients suffer from poor long-term survival rates and 
lower levels of health-related quality of life. However, home hemodialysis is a historically 
significant dialysis modality that has been associated with favorable outcomes as well as greater 
patient autonomy and control, yet only represents a small minority of the total dialysis performed 
in the United States. Some potential disadvantages of home hemodialysis include vascular access 
complications, infection-related hospitalizations, patient fatigue and attrition. In addition, current 
barriers and challenges in expanding the utilization of this modality include limited patient and 
provider education and technical expertise. Here we report a 65-year old male with end-stage renal 
disease due to Alport’s Syndrome who has undergone 35 years of uninterrupted thrice-weekly 
home hemodialysis (i.e., every Sunday, Tuesday, and Thursday evening, each session lasting 3 to 
3¼ hours in length) using a conventional hemodialysis machine who has maintained a high 
functional status allowing him to work six to eight hours per day. The patient has been able to 
liberalize his dietary and fluid intake while only requiring three to four liters of ultrafiltration per 
treatment, despite having absence of residual kidney function. Through this case of extraordinary 
longevity and outcomes after 35 years of dialysis and a review of the literature, we illustrate the 
history of home hemodialysis, its significant clinical and psychosocial advantages, as well as the 
barriers that hinder its widespread adaptation.
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INTRODUCTION
Home hemodialysis represents a small but increasing proportion of dialysis treatments 
utilized in the United States. In this case report, we describe a patient who receives home 
hemodialysis on a thrice-weekly basis with an exceptional dialysis vintage exceeding 35 
years. In addition, a brief overview of the history of home hemodialysis and its current 
epidemiology, outcomes data, clinical advantages and limitations, and future research 
directions of this renal replacement modality is provided.
CASE
The patient is a 65-year old Asian American male with a history significant for end stage 
renal disease secondary to Alport’s Syndrome. His family history is notable for Alport’s 
syndrome in his sister as well as both of his daughters. The patient was first diagnosed with 
chronic kidney disease with heavy proteinuria and hematuria at age 18 (Figure 1), and he 
underwent a kidney biopsy at age 19 confirming the diagnosis of Alport’s Syndrome. The 
patient’s kidney disease gradually progressed over time, and by the age of 28 he initiated in-
center thrice-weekly hemodialysis. After three months of in-center hemodialysis, he then 
transitioned to thrice-weekly home hemodialysis. The patient’s wife received formal 
hemodialysis training and was primarily responsible for assisting him with completion of his 
dialysis treatments. Due to limitations in the efficiency of his dialysis treatment related to 
antiquated dialysis membranes and lack of high-flux dialyzers, he was initially prescribed 
four-hour dialysis treatments three times per week to achieve adequate clearance. However, 
as high-flux dialyzers became widely available, his dialysis duration was shortened to 
approximately three hours to three hours and fifteen minutes per treatment. The patient was 
educated about peritoneal dialysis as a potential alternative dialysis modality, but given his 
concerns about the potential complications (e.g., peritoneal infections), he opted for 
hemodialysis instead.
Since the age of 29, the patient has had a long series of dialysis accesses. His first vascular 
access was a left upper extremity arteriovenous graft (AVG) with five subsequent revisions 
to his AVG with intermittent requirement of temporary tunneled dialysis catheters on 
multiple occasions. At the age of 45, the patient underwent construction of a right 
brachiocephalic arteriovenous fistula (AVF), which has remained functional and has 
continued to serve as his primary vascular access until the present day.
The patient continued to have residual kidney function for the first five years following 
initiation of hemodialysis, but he became anuric by the age of 35. The patient was previously 
evaluated for kidney transplantation, but declined this intervention due to work obligations 
and inability to take time off. In addition, the patient was identified as having two vessel 
coronary disease with right coronary artery and left anterior descending arterial involvement 
(Figure 2), as well as a left ventricular systolic function of 52% with mild to moderate aortic 
regurgitation and moderately elevated pulmonary artery systolic pressure shown on most 
recent echocardiogram.
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His most recent chest radiography showed a small chronic right pleural effusion as well as 
Rugger-Jersey sign synonymous with hyperparathyroidism (Figure 3) in the context of an 
intact parathyroid hormone level of 731 pg/mL, corrected serum calcium of 8.7 mg/dL, and 
serum phosphorus of 6.3 mg/dL. His current chronic kidney disease mineral bone disorder 
medication regimen includes paricalcitol 2 mcg daily and cinacalcet 30 mg daily. His 
phosphorus binder regimen consists of sucroferric oxyhydroxide 1 tablet with meals, and 
sevelamer 3200 mg with meals. With respect to his anemia management, he is currently 
receiving intravenous iron sucrose 100 mg monthly and methoxy polyethylene glycol-
epoetin beta (Mircera) 50 mcg every 2 weeks.
With respect to his nutritional status, the patient has been able to consume a liberal diet. He 
has not closely enumerated phosphorus or protein contents in his diet but has generally 
avoided foods that are replete with phosphorus and potassium. Most of his meals are 
prepared at home, consisting primarily of “simple Chinese foods” (e.g., white rice, stir fried 
vegetables, select meats). He endorses eating out at restaurants two to three times per week. 
The patient denies any difficulties in maintaining his appetite and has had to restrict total 
dietary intake to prevent excessive weight gain.
Using his own financial resources, the patient was able to install an adequate plumbing and 
water purification into his private residence to accommodate the usage of a conventional 
hemodialysis machine. In addition, he was able to acquire the services of in-home dialysis 
nursing staff to aid in the cannulation of his arteriovenous fistula and execution of dialysis. 
Since the advent of high-flux dialyzers, the patient has consistently adhered to a thrice-
weekly dialysis schedule with session lengths of no more than three hours and fifteen 
minutes due to fatigue with longer treatment durations. If his dialysis adequacy as 
ascertained by his single-pool Kt/V falls below target, the flexibility of home hemodialysis 
allows him to increase his treatment frequency to four times per week. Average 
ultrafiltration volume per dialysis treatment has typically ranged between three to four liters. 
In terms of his treatment schedule, each hemodialysis session is usually initiated at six PM 
and ends between nine to ten PM, after which time the patient usually stays awake for an 
additional two to three hours prior to sleeping.
The flexibility of home hemodialysis has allowed the patient to maintain an active lifestyle. 
For example, he is the owner of a biotechnology company which requires frequent travel, 
and he visits international destinations at least annually. Furthermore, he has maintained a 
high functional status and regularly attends ballroom dance lessons with his wife twice per 
week. Notably, the patient has a strong belief in the efficacy of traditional Eastern 
medications and specifically musculoskeletal manipulation of reflexology as hypothesized to 
relate to the optimal function of individual organ systems. He performs foot, hand, and body 
massages daily, which he credits as maintaining optimal control of serum calcium and 
phosphorus. He does not, however, partake in herbal supplementation.
While there are multiple aspects that have contributed to this patient’s exceptional longevity 
(i.e., ample social support, adequate nutritional intake, principal use of an AVF/AVG), the 
overarching predominant factor has been the patient’s ability to undergo dialysis in the home 
setting. The heightened autonomy, flexibility, and control that the patient has been able to 
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experience through the receipt of home hemodialysis has also provided him with greater 
empowerment to be self-directed and wholly engaged in his care, while also allowing him to 
maintain an active lifestyle and a high level of socialization and independence. Hence, the 
remainder of this review will focus upon home hemodialysis as a modality that has the 
potential to optimize patient survival and health-related quality of life.
DISCUSSION
History of Home Hemodialysis
Home hemodialysis was once a widely utilized renal replacement modality first 
implemented in 1964 by three groups located broadly in Seattle, Boston, and London with 
the first report of overnight unattended hemodialysis described in the United Kingdom in 
1965.1 Early hemodialysis treatments were largely conducted in a home setting due to a lack 
of hospital and clinic based facilities. In 1973, home hemodialysis was used by nearly 40% 
of all dialysis patients in the United States, and the United States Congress passed social 
security amendments that created a Medicare program to pay for dialysis treatment, 
incentivizing the building of dialysis units and the rising utilization of in-center 
hemodialysis2. The advent of peritoneal dialysis in the 1970’s and 1980’s provided further 
alternatives for home hemodialysis, reducing its popularity.2 By the early 2000’s, only 
Australia, New Zealand, and Turkey had substantial numbers of patients on home 
hemodialysis3. In 1994, slow, frequent, nocturnal home hemodialysis was first implemented 
in a Canadian center4. Advancements in dialysis technology over the past two decades have 
led to greater access to home hemodialysis. Currently multiple dialysis machines have been 
commissioned for home hemodialysis including the Aksys PHD machine (Aksys Ltd., 
Lincolnshire, IL), NxStage System One (NxStage Medical, Inc., Lawrence, MA), and the 
Fresenius 2008K@HOME (Fresenius USA Inc., Walnut Creek, CA).5 Due to its relatively 
small size, low flow fraction and thus low volume dialysate use, and lack of requirement for 
home water treatment system installation, NxStage System One has been the most 
commonly employed system in the United States to date.
Epidemiology of Home Hemodialysis
Home hemodialysis represents a small but increasing fraction of renal replacement therapy 
utilized by both incident and prevalent end stage renal disease patients in the United States. 
Representing <1% of total dialysis in 20052, the incidence of home hemodialysis has risen 
by 120% over the period of 2007 to 2014, but is still only utilized by 3.4% of all incident 
hemodialysis patients. Among the prevalent end stage renal disease population, total home 
dialysis (including both peritoneal dialysis and home hemodialysis) increased from 8.7% in 
2008 to 11.6% in 2014.6 Among patients treated with home dialysis, the proportion of those 
using home hemodialysis rose from 6.2% in 2000 to 15.6% in 2014, a 2.5 fold increase6.
Home Hemodialysis Outcomes
Mortality—In the Frequent Hemodialysis Network trial, 52 end stage renal disease patients 
were randomized to undergo thrice weekly in-center hemodialysis vs. six times weekly 
nocturnal hemodialysis. Although the trial was not sufficiently powered to show differences 
in mortality, patients in the frequent nocturnal hemodialysis group were noted to have 
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greater improvement in mean left ventricular mass7. While this trial focused upon in-center 
hemodialysis patients, the favorable effects of more frequent hemodialysis may also be 
observed with home hemodialysis, particularly given the flexibility in treatment schedules of 
home-based dialysis therapies.
Risk factors associated with increased mortality in home hemodialysis patients include 
increasing age, diabetes, and smoking.8 In a large retrospective analysis of 2840 incident 
home hemodialysis patients, one-year mortality for patients on home hemodialysis was 
7.6%, with 24.9% of patients undergoing discontinuation of home hemodialysis during this 
time period. In this study, factors associated with discontinuation of home hemodialysis 
included diabetes, tobacco use, alcohol, and recreational drug use9 In comparison to 
peritoneal dialysis, home hemodialysis has been associated with a 20% lower risk of all-
cause mortality, and 30% reduction in risk for technique failure.10 Home hemodialysis, 
however, has not shown mortality benefits when compared to kidney transplantation. A 
prospective study of 480 incident US home hemodialysis and 480 matched incident kidney 
transplant patients showed that, as compared to kidney transplant, home hemodialysis has 
been associated with a four-fold higher risk of death.11
Patient centered outcomes—Data from a large observational study comparing six-
times per week home hemodialysis vs. thrice weekly in-center hemodialysis are also 
available and have shown greater improvement in health-related quality of life, reductions in 
depression, and decreases in post-dialysis recovery time with the former modaliy.12 
Furthermore, nocturnal home hemodialysis offers a significant psycho-social advantage to 
conventional in-center hemodialysis including less disruption of daytime schedules, less 
travel to clinic, better quality of sleep, greater time allotment for work and time spent with 
family, as well as improved sexual function.13
Complications—Home hemodialysis may also be associated with some complications. In 
a randomized control trial of 87 hemodialysis patients randomized to conventional thrice-
weekly in-center hemodialysis vs. six days per week nocturnal hemodialysis, a trend towards 
higher risk of need for access repair, access loss, or access hospitalization was observed in 
patients undergoing nocturnal hemodialysis14. In addition, home hemodialysis has been 
associated with higher rates of hospitalization due to vascular access infections in 
comparison to conventional in-center hemodialysis.15 Among home hemodialysis patients, 
the use of central venous catheters was associated with the highest rates of hospitalization.16
Future Research Directions
Despite the advantages of home hemodialysis, significant barriers exist in its widespread 
implementation including lack of adequate resources for patient education and training, 
limited provider experience, technical complexities of operating a dialysis machine, and 
greater water purification requirements.17 At this time, current knowledge gaps and future 
research directions relating to home hemodialysis include 1) the identification of patients 
who are optimal for this dialysis modality, 2) development of more streamlined and portable 
home hemodialysis technologies,18 3) improvements in home hemodialysis vascular access 
durability,2,19 4) greater incorporation of telemedicine for home therapies,20 and 5) the role 
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of home hemodialysis in pediatric end stage renal disease patients.21 Further investigations 
are needed to demonstrate home hemodialysis as a robust modality of renal replacement 
therapy.
CONCLUSION
End stage renal disease patients receiving maintenance hemodialysis suffer from high 
mortality rates and restricted health-related quality of life6. In this case report, we delineated 
the experience of a patient with end stage renal disease on an unconventional yet successful 
thrice-weekly nocturnal home hemodialysis regimen. The patient had the added benefit of 
having the financial resources to allow for home water system modification, private nursing 
staff, and the use of a conventional hemodialysis machine in lieu of traditional home 
hemodialysis systems. Access to home hemodialysis has allowed the patient to maintain an 
active, highly functional lifestyle, with minimal restrictions to his vocational and personal 
responsibilities, while also achieving an unparalleled dialysis vintage, giving new meaning 
to the adage, “There’s no place like home.” Hence, further studies are needed to expand 
access of home hemodialysis as a feasible and successful dialysis modality across a broader 
population of patients.
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Figure 1. 
Timeline of history of home hemodialysis (upper panel), patient’s clinical course on home 
hemodialysis (middle panel), and significant historical events (lower panel).
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Figure 2. 
Chest computed tomography scan with calcium scoring. Note heavily calcified coronary 
vessels.
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Figure 3. 
Chest radiography illustrating severe renal osteodystrophy and Rugger-Jersey spine.
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